Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;58(2):326-331.
doi: 10.2967/jnumed.116.176891. Epub 2016 Aug 18.

2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine PET

Affiliations

2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine PET

Ka Kit Wong et al. J Nucl Med. 2017 Feb.

Abstract

The objective of this study was to detect regional patterns of cardiac sympathetic denervation in idiopathic Parkinson disease (IPD) using 11C-hydroxyephedrine (11C-HED) PET and determine the denervation rate over 2 y.

Methods: We obtained 62 cardiac 11C-HED PET scans in 39 patients (30 men and 9 women; mean age ± SD, 61.9 ± 5.9 y), including 23 patients with follow-up scans at 2 y. We derived 11C-HED retention indices (RIs; mL of blood/min/mL of tissue) reflecting nerve density and integrity for 480 left ventricular (LV) sectors. We compared IPD patients with 33 healthy controls using z score analysis; RI values ≤ 2.5 SDs were considered abnormal. We expressed global and regional LV denervation as the percentage extent of z score severity and severity-extent product (SEP) on 9-segment bullseye maps and decline in cardiac sympathetic innervation as the 2-y difference in SEP (diff-SEP).

Results: Baseline 11C-HED PET in the 39 IPD patients revealed an RI mean of 0.052 ± 0.022 mL of blood/min/mL of tissue. In comparison with data from normal controls, 12 patients had normal 11C-HED PET, 5 showed mild denervation (percentage extent < 30%), and 22 had moderate to severe denervation (percentage extent > 30%, z score ≤ 2.5 SD). In the 23 paired PET scans, worsening cardiac denervation (global diff-SEP > 9) occurred in 14 of 23 (60.9%) patients over 2 y, including percentage LV abnormality (59% increasing to 66%), z-severity (-2.4 down to -2.5), and SEP (-195 to -227) (P = 0.0062). We found a mean annual decline of 4.6% ± 5.6 (maximum, 13%) in 11C-HED retention from a baseline global RI mean of 0.0481 ± 0.0218 to 0.0432 ± 0.0220 (P = 0.0009). At baseline, 5 patients with normal uptake had no interval change; 3 with mild denervation developed interval decline in lateral and inferior segments (diff-SEP -82 to -99) compared with anterior and septal segments (-65 to -79), whereas the reverse pattern occurred in 15 patients with severe baseline denervation.

Conclusion: Progressive decline in cardiac sympathetic neural integrity in IPD patients occurs at a modest rate over 2 y on 11C-HED scans with marked heterogeneity and a regional pattern of involvement and decline.

Keywords: 11C-hydroxyephedrine PET; Parkinson disease; autonomic nervous system; cardiac sympathetic denervation.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Bullseye plots using 9-segment model summarizing segmental distribution of sympathetic denervation with respect to mean percentage extent, z score severity, and SEP, in comparison to global mean measurements in 23 patients, comparing baseline measurements with 2-y follow-up. There is a decline in global LV RI per annum of 4.6% translating to increasing abnormalities of LV segmental extent, z score severity, and SEP. Over 2 y, changes in percentage LV abnormality (59% increasing to 66%), z score severity (–2.4 down to –2.5), and SEP (–195 down to –227) indicate worsening cardiac sympathetic innervation. There is a general proximal-to-distal gradient, with basal segments being relatively spared compared with distal segments.
FIGURE 2.
FIGURE 2.
Bullseye plots summarizing decline in sympathetic denervation with respect to SEP, in 23 patients, comparing differences in baseline measurements with 2-y follow-up of SEP, based on starting category at baseline, either mild abnormality or severe. In patients with severe denervation at baseline preferentially affecting lateral wall, anterior and septal walls showed relatively greater decline, whereas patients with mild abnormality on PET scans at baseline had relatively greater progression in lateral, inferior, and apical walls. Patients with normal baseline 11C-HED PET had small changes that were not considered significant within margin of test–retest error for 11C-HED PET. Formal reproducibility analysis of 11C-HED is an area of future research.
FIGURE 3.
FIGURE 3.
Comparison polar maps of normal control patients’ (n = 33) mean 11C-HED RIs (A) and baseline IPD patients’ (n = 23) mean 11C-HED RIs (B), demonstrating severe, global cardiac sympathetic denervation. (C) Mean difference in RI between baseline studies and 2-y follow-up studies demonstrating preferentially decline in anteroseptal and septal walls. (D) Segmental z score severity polar map, generated by sector-to-sector comparison of IPD and normal control 11C-HED RI, representing characteristic regional pattern of sympathetic denervation in IPD. Proximal lateral wall is most severely affected, with relative sparing of anterior and proximal septal walls. (E) There is concordance in segmental distribution on both z score severity polar map and frequency polar map representing percentage of IPD patients (i.e., n/23 × 100) with abnormal sector z score ≤ 2.5 displayed on color scale ranging from 0% to 100%.
FIGURE 4.
FIGURE 4.
Examples of 11C-HED decline in IPD patients showing baseline 11C-HED RI (left), 2-y follow-up 11C-HED RI (middle), and difference 11C-HED RI (right) polar maps. (A) Partial 11C-HED denervation at baseline 11C-HED scan, with decline in 11C-HED uptake at 2 y, after initial sparing of anterior and septal walls. (B) Severe 11C-HED denervation at baseline, with mild further decline at 2 y, in septum and inferior LV walls.

References

    1. Ryan BJ, Lourenco-Venda LL, Crabtree MJ, Hale AB, Channon KM, Wade-Martins R. α-synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease. Free Radic Biol Med. 2014;67:58–68. - PMC - PubMed
    1. Jellinger KA. Synuclein deposition and non-motor symptoms in Parkinson disease. J Neurol Sci. 2011;310:107–111. - PubMed
    1. Akincioglu C, Unlu M, Tunc T. Cardiac innervation and clinical correlates in idiopathic Parkinson’s disease. Nucl Med Commun. 2003;24:267–271. - PubMed
    1. Hamada K, Hirayama M, Watanabe H, et al. Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2003;74:423–426. - PMC - PubMed
    1. Kim JS, Lee KS, Song IU, et al. Cardiac sympathetic denervation is correlated with Parkinsonian midline motor symptoms. J Neurol Sci. 2008;270:122–126. - PubMed

Publication types

LinkOut - more resources